| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/27/2004 | CN1172718C Dendritic cell stimulatory factor |
| 10/27/2004 | CN1172714C Patent Chinese medicine for curing vascular headache |
| 10/27/2004 | CN1172713C Chinese patent medicine for treating cancer |
| 10/27/2004 | CN1172711C Chinese medicine preparation for curing chronic conjunctivitis |
| 10/27/2004 | CN1172701C Medicine for curing herpes zoster |
| 10/27/2004 | CN1172700C External applied medicine for curing burn and preparing method thereof |
| 10/27/2004 | CN1172699C Chinese medicine for treating syringomyelia |
| 10/27/2004 | CN1172695C Medicine for preventing and treating senile dementia |
| 10/27/2004 | CN1172688C External medicine for treating tympanitis |
| 10/27/2004 | CN1172686C Pearl nano-materials preparing method |
| 10/26/2004 | US6808922 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 10/26/2004 | US6808916 Method of extracting virus from cell culture |
| 10/26/2004 | US6808877 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
| 10/26/2004 | US6808705 For suppressing the proliferation of cancer cells |
| 10/26/2004 | US6808704 Removing nuclear dna from recipient oocyte to form nuclear transfer agent; activating and culturing to generate non-human embryo; injecting into donor mammal; examining site for teratoma and signs of rejection |
| 10/26/2004 | US6808703 Lactobacillus for use in he treatment of eating disorders and pancreatic defects |
| 10/26/2004 | US6808702 Repopulation of cellular components (neurons, muscles, tissues); for treatment of degenerative, immunologic/ inflammatory, neoplastic, and idiopathic conditions of the gastrointestinal tract |
| 10/26/2004 | CA2137237C Purified forms of dnase |
| 10/21/2004 | WO2004090121A2 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| 10/21/2004 | WO2004090120A2 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 10/21/2004 | WO2004090118A1 Lactobacillus plantarum strain st-iii and its use in adjusting blood fat |
| 10/21/2004 | WO2004090112A2 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 10/21/2004 | WO2004090096A2 Methods for neural differentiation of embryonic stem cells using protease passaging techniques |
| 10/21/2004 | WO2004090095A2 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders |
| 10/21/2004 | WO2004089956A1 Novel amino acid dysiherbaine |
| 10/21/2004 | WO2004089439A2 Elective collection and banking of autologous peripheral blood stem cells |
| 10/21/2004 | WO2004089407A2 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 10/21/2004 | WO2004089386A1 Antiobestic agent using hen’s egg antibody against digestive enzymes |
| 10/21/2004 | WO2004089385A2 An ayurvedic nutritional preparation |
| 10/21/2004 | WO2004089290A2 Novel probiotic compositions and methods of using the same |
| 10/21/2004 | WO2004089278A2 Sexual hygienic composition |
| 10/21/2004 | WO2004089189A2 Minimally-invasive imaging of viral gene therapy and presurgical applications thereof |
| 10/21/2004 | WO2004089115A1 Synbiotic combination |
| 10/21/2004 | WO2004089097A1 Composition with heart rate reducing properties |
| 10/21/2004 | WO2004044142A3 Mesenchymal stem cells and methods of use thereof |
| 10/21/2004 | WO2004013275A8 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 10/21/2004 | WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 10/21/2004 | WO2003026490A3 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 10/21/2004 | US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS) |
| 10/21/2004 | US20040209851 Bear derived isolate and method |
| 10/21/2004 | US20040209840 Manipulation of arterial-venous identity |
| 10/21/2004 | US20040209818 Immunomodulating polymers |
| 10/21/2004 | US20040209813 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases |
| 10/21/2004 | US20040209805 such as fibrosis via activin antagonist (fullistatin); kits; gene therapy; treating inflammatory bowel disease and crohn's disease |
| 10/21/2004 | US20040209801 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits |
| 10/21/2004 | US20040209359 Freeze-dried biocompatible matrix/biological scaffold comprising plasma proteins for use as implants in tissue engineering and biotechnology; wound healing agents |
| 10/21/2004 | US20040209357 Hematopoietic stem cells treated by in vitro fucosylation and methods of use |
| 10/21/2004 | US20040209333 administering subtilisins obtained from grampositive bacterial residues that vitamin k2 has been removed using chitosan |
| 10/21/2004 | US20040209314 Comprises multimer of major histocompatibility complex which binds peptide-specific CD8+ T lymphocyte populations for use as diagnostic components of immunoassay; immunotherapy |
| 10/21/2004 | US20040209250 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 10/21/2004 | US20040209240 Anti-neoplastic viruses |
| 10/21/2004 | US20040208943 Method for treatment of skin disorders |
| 10/21/2004 | US20040208916 Patch for the transdermal administration of beneficial substances |
| 10/21/2004 | US20040208915 Transdermal administration device for animals |
| 10/21/2004 | US20040208897 microbial cell comprising an Environmentally Limited Viability System made of an essential and a lethal gene ; cell is viable in a permissive environment and non-viable or temporarily viable in a non-permissive environment |
| 10/21/2004 | US20040208896 Immunotherapy for humans |
| 10/21/2004 | US20040208889 Pharmaceutical use for secreted bacterial effector proteins |
| 10/21/2004 | US20040208863 Anti-inflammatory activity from lactic acid bacteria |
| 10/21/2004 | US20040208861 Stromal cell use |
| 10/21/2004 | US20040208860 Use of emu oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 10/21/2004 | US20040208859 Bile acid absorbent/adsorbent |
| 10/21/2004 | US20040208858 Causing mesenchymal stromal cells differentiate into neuron and oligodendrocyte cells to compensate for said neurological deterioration or damaged myelin; Parkinson*s, Tay-Sach*s, and Alzheimer*s disease; strokes, trauma,ganglioside storage dysfunction or demyelinization; multiple sclerosis |
| 10/21/2004 | US20040208857 Producing a donor-specific immunotolerance against transplanted tissue by administering embryonic stem cell-like cell lines (ECL) obtained from blastocysts and are transfected with genetic material of the donor, which codes for the major histocompatibility complex (MHC) haplotypes |
| 10/21/2004 | US20040208854 Methods and compositions for controlled release of bioactive compounds |
| 10/21/2004 | US20040208851 Immunization by inoculation of DNA transcription unit |
| 10/21/2004 | US20040208849 Reducing viability of tumor cell by administering virus that is not a common human pathogen such as a Rhabdovirus, a picomavirus, and preferably is vesicular stomatitis virus (VSV) |
| 10/21/2004 | US20040208786 Autologous coagulant produced from anticoagulated whole blood |
| 10/21/2004 | CA2809195A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 10/21/2004 | CA2784829A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 10/21/2004 | CA2548580A1 Elective collection and banking of autologous peripheral blood stem cells |
| 10/21/2004 | CA2521997A1 Antiobestic agent using hen's egg antibody against digestive enzymes |
| 10/21/2004 | CA2521855A1 Feminine hygiene composition comprising an equid milk extract |
| 10/21/2004 | CA2521631A1 Composition with heart rate reducing properties |
| 10/21/2004 | CA2521380A1 Synbiotic combination |
| 10/21/2004 | CA2521217A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 10/21/2004 | CA2521039A1 Methods for neural differentiation of embryonic stem cells using protease passaging techniques |
| 10/21/2004 | CA2520865A1 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 10/21/2004 | CA2520023A1 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 10/21/2004 | CA2519975A1 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| 10/21/2004 | CA2519927A1 Novel probiotic compositions and methods of using the same |
| 10/21/2004 | CA2488927A1 An ayurvedic nutricinal preparation |
| 10/20/2004 | EP1469077A1 Cell-specific expression/replication vector |
| 10/20/2004 | EP1469075A1 Gene-therapy for solid tumors, papillomas and warts |
| 10/20/2004 | EP1468713A2 Systems and methods for collecting diluted mononuclear cells |
| 10/20/2004 | EP1468119A2 A METHOD OF DEVELOPING AN ANTI−PROTEIN AND REGULATION OF A CELLULAR FUNCTION BY ADMINISTERING AN EFFECTIVE AMOUNT OF THE ANTI−PROTEIN |
| 10/20/2004 | EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS |
| 10/20/2004 | EP1468094A1 Method of transducing es cells |
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468088A2 Stem cell maturation for all tissue types |
| 10/20/2004 | EP1468075A1 Novel lactobacillus sp. strain and use thereof |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1468014A2 Compositions and methods for wt1 specific immunotherapy |
| 10/20/2004 | EP1467748A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 10/20/2004 | EP1467719A2 Method and device for feeding living cells into a biological body fluid |
| 10/20/2004 | EP1467624A2 Methods of inducing or enhancing connective tissue repair |
| 10/20/2004 | EP1465643A4 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 10/20/2004 | EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 10/20/2004 | EP1207892B1 Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals |
| 10/20/2004 | EP1181381B1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |